Current vitamin D dosing recommendations not high enough for optimal heart health, studies suggest

Low levels of Vitamin D have been shown to be associated with a higher risk of having a cardiac event, like a heart attack or stroke.

Half-year results 2024 of SartoriusStedimBiotech – Biotech Investments

Sartorius Stedim Biotech SA / Key word(s): Half Year Results Half-year results 2024 of SartoriusStedimBiotech 18-Jul-2024 / 18:30 CET/CEST Aubagne, France | July 19, 2024

July 19, 2024

Managing Technical Debt in Healthcare: A Guide for Hospitals

Dave Lamar, Chief Growth Officer of MediQuant Organizations of every size and industry experience challenges associated with technical debt, which refers to future costs and

December 2, 2024

VORANIGO approved by Health Canada for IDH-mutant glioma

VORANIGO, a dual inhibitor of mutant IDH1 and IDH2 enzymes, is designed to penetrate the blood-brain barrier. Credit: CNW Group/Servier Canada. Servier Canada has announced

October 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.